Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chabner

Showing results (341-350 of 456) with videos related to

Pageof 46
Sort By:
JCO Oncology Practice|June 6, 2022
Financial Toxicity, Symptom Burden, Illness Perceptions, and Communication Confidence in Cancer Clinical Trial ParticipantsSubha Perni, Chukwuma Azoba, Emily Gorton, et al.
Seminars in Oncology|December 1, 1992
Recent National Cancer Institute lymphoma trials of etoposide-containing combination chemotherapyW J Urba, W H Wilson, P L Duffey, et al.
The New England Journal of Medicine|April 28, 1983
Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered?S Zimm, J M Collins, R Riccardi, et al.
The Oncologist|February 15, 2005
Fear of deathRichard T Penson, Rosamund A Partridge, Muhammad A Shah, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1996
AntimetabolitesP G Johnston, C H Takimoto, J L Grem, et al.
The British Journal of Cancer. Supplement|March 1, 1975
Therapy of advanced lymphocytic lymphoma a preliminary report of a randomized trial between combination chemotherapy (CVP) and intensive radiotherapyG P Canellos, V T DeVita, R C Young, et al.
British Medical Journal|January 4, 1975
Letter: Combination chemotherapy for breast cancerG P Canellos, V T DeVita, G L Gold, et al.
The Oncologist|May 25, 1999
A staff dialogue on caring for a cancer patient who commits suicide: psychosocial issues faced by patients, their families, and caregiversE M O'Shea, K C Lintz, R T Penson, et al.
Cancer|January 15, 1993
Age does not influence taxol dose intensity in recurrent carcinoma of the ovaryA Bicher, G Sarosy, E Kohn, et al.
Bulletin Du Cancer|January 1, 1979
Potential clinical applications of a new method for quantitation of plasma levels of 5-fluorouracil and 5-fluorodeoxyuridineR A Jones, A R Buckpitt, H H Londer, et al.
Pageof 46

Showing results (341-350 of 456) with videos related to

Sort By:
Pageof 46
JCO Oncology Practice|June 6, 2022
Financial Toxicity, Symptom Burden, Illness Perceptions, and Communication Confidence in Cancer Clinical Trial ParticipantsSubha Perni, Chukwuma Azoba, Emily Gorton, et al.
Seminars in Oncology|December 1, 1992
Recent National Cancer Institute lymphoma trials of etoposide-containing combination chemotherapyW J Urba, W H Wilson, P L Duffey, et al.
The New England Journal of Medicine|April 28, 1983
Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered?S Zimm, J M Collins, R Riccardi, et al.
The Oncologist|February 15, 2005
Fear of deathRichard T Penson, Rosamund A Partridge, Muhammad A Shah, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1996
AntimetabolitesP G Johnston, C H Takimoto, J L Grem, et al.
The British Journal of Cancer. Supplement|March 1, 1975
Therapy of advanced lymphocytic lymphoma a preliminary report of a randomized trial between combination chemotherapy (CVP) and intensive radiotherapyG P Canellos, V T DeVita, R C Young, et al.
British Medical Journal|January 4, 1975
Letter: Combination chemotherapy for breast cancerG P Canellos, V T DeVita, G L Gold, et al.
The Oncologist|May 25, 1999
A staff dialogue on caring for a cancer patient who commits suicide: psychosocial issues faced by patients, their families, and caregiversE M O'Shea, K C Lintz, R T Penson, et al.
Cancer|January 15, 1993
Age does not influence taxol dose intensity in recurrent carcinoma of the ovaryA Bicher, G Sarosy, E Kohn, et al.
Bulletin Du Cancer|January 1, 1979
Potential clinical applications of a new method for quantitation of plasma levels of 5-fluorouracil and 5-fluorodeoxyuridineR A Jones, A R Buckpitt, H H Londer, et al.
Pageof 46